Skip to content

Drug prices are too high. What is Congress trying to do about it?

Chairman Charles E. Grassley, right, and ranking member Sen. Ron Wyden are seen before a Senate Finance Committee on drug pricing in America on February 26, 2019. (Tom Williams/CQ Roll Call)
Chairman Charles E. Grassley, right, and ranking member Sen. Ron Wyden are seen before a Senate Finance Committee on drug pricing in America on February 26, 2019. (Tom Williams/CQ Roll Call)

Both the House and the Senate have competing bills aimed at addressing the rising costs of prescription drugs, a legislative priority backed by President Donald Trump.

But what would these various proposals accomplish, and how likely is it they’ll be signed into law?

[jwp-video n=”1″]

Recent Stories

Court challenges mount over Trump’s funding clawback

Schmitt show  — Congressional Hits and Misses

Photos of the week | September 25-October 1, 2026

House Democrats grow more bullish about midterms as target list expands

Guns, voting and immigration on deck for Supreme Court

‘Pain in the ass’: Trump again shows annoyance with Paxton after leaked audio